U.S. Markets closed

Will the ResVax Vaccine Be Key Revenue Driver for Novavax?

Margaret Patrick
Will the ResVax Vaccine Be Key Revenue Driver for Novavax?

Is Novavax an Attractive Pick after First-Quarter Results?(Continued from Prior Part)Resvax vaccine updatesOn February 28, Novavax (NVAX) issued a press release announcing results from the first-ever Phase 3 trial for PrepareTM, evaluating the